Decrements in health-related quality of life associated with adverse events in people with diabetes.

These estimated decrements in QoL associated with cardiovascular, bleeding, cancer and other adverse events can inform assessments of overall value of treatments in patients with diabetes. This article is protected by copyright. All rights reserved.